Dergiler / Gülhane Tıp Dergisi / 2018 / Cilt: 60 - Sayı: 2

Meropenem induced mixed hepatocellular and cholestatic hepatitis: A report of two cases

Sayfa
64–66
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In the differential diagnosis of liver enzyme abnormalities after meropenem treatment, physicians should also prompt suspicion of an adverse drug reaction.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Drug-induced liver injury (DILI) is common clinic issue in clinical practice and might be induced by almost all drugs.
📊
Temel Bulgular & Veri:Antibiotics (especially beta-lactams) are one of the leading cause due to their widespread use.
💡
Sonuç & Katkı:In the differential diagnosis of liver enzyme abnormalities after meropenem treatment, physicians should also prompt suspicion of an adverse drug reaction.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Drug-induced liver injury (DILI) is common clinic issue in clinical practice and might be induced by almost all drugs. Antibiotics (especially beta-lactams) are one of the leading cause due to their widespread use. Albeit rare, meropenem may cause DILI, even shortly after its administration. Here we report our experience of two cases with cholestatic hepatitis that occured after meropenem use. In the differential diagnosis of liver enzyme abnormalities after meropenem treatment, physicians should also prompt suspicion of an adverse drug reaction.

🔖

Bu Makaleye Atıf Yap

BAŞGÖZ, B. B., MEHMETZADE, N., EDİBOĞLU, E. E., TAŞÇI, İ., SAĞLAM, K. (2018). Meropenem induced mixed hepatocellular and cholestatic hepatitis: A report of two cases. Gülhane Tıp Dergisi, Cilt: 60 - Sayı: 2, 64–66. https://ajindex.com/articles/165009

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (4)

  1. Linden P. Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem. Drug safety. 2007;30(8):657-668.
  2. Batt AM, Ferrari L. Manifestations of chemically induced liver damage. Clinical chemistry. 1995;41(12 Pt 2):1882- 1887. Mohankumar N, Ranjan P, Kumari A. Drug-induced liver injury: Diagnosing (and treating) it early. The Journal of family practice. 2015;64(10):634-644.
  3. Stirnimann G, Kessebohm K, Lauterburg B. Liver injury caused by drugs: an update. Swiss medical weekly. 2010;140:w13080. Chang CY, Schiano TD. Review article: drug hepatotoxicity. Alimentary pharmacology & therapeutics. 2007;25(10):1135-1151.
  4. Navarro VJ, Senior JR. Drug-related hepatotoxicity. The New England journal of medicine. 2006;354(7):731-739.